Bank of Montreal
JSPR icon

Bank of Montreal’s Jasper Therapeutics JSPR Stock Holding History

Bank of Montreal’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-111,802
Closed -$266K – 3720
2025
Q3 		$266K Sell
111,802
-46,331
-29% -$140K ﹤0.01% 2592
2025
Q2 		$878K Buy
158,133
+86,393
+120% +$425K ﹤0.01% 1974
2025
Q1 		$308K Buy
+71,740
New +$477K ﹤0.01% 2501
2024
Q2 		– Sell
-69,100
Closed -$812K – 4074
2024
Q1 		$812K Buy
69,100
+34,270
+98% +$609K ﹤0.01% 2125
2023
Q4 		$279K Buy
+34,830
New +$234K ﹤0.01% 2913

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bank of Montreal's JSPR Position: Q4 2025 in Review

Bank of Montreal sold out of Jasper Therapeutics (JSPR) in Q4 2025, closing a stake of 111,802 shares — an estimated $266K sold.

Bank of Montreal first reported a position in JSPR in Q4 2023 and held it in 5 quarters. The position peaked at $878K in Q2 2025. 55 funds tracked by Wall St. Rank hold JSPR as of Q4 2025.

  • Bank of Montreal reported no remaining Jasper Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Bank of Montreal sold 111,802 Jasper Therapeutics shares in Q4 2025, an estimated $266K.
  • Bank of Montreal first reported a position in Jasper Therapeutics in Q4 2023 and held it in 5 quarters.
  • Bank of Montreal's Jasper Therapeutics position peaked at $878K in Q2 2025.
  • 55 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2025.

Based on Bank of Montreal's 13F filing for Q4 2025, filed 12 Feb 2026.